McDermott, Eugene W.

Eugene W. McDermott Jr.

Partner
RELATED SERVICES

Gene McDermott practices in the area of corporate and securities law, with emphasis on capital markets, corporate governance, issuer reporting requirements and mergers and acquisitions. He advises clients involved in public and private offerings of equity and debt, both in the United States and internationally. His work regularly includes general securities advice, tender offers, public and private merger and acquisition transactions and "alternative" public offerings, such as registered directs, PIPEs, at-the-market offering programs and confidentially marketed public offerings (CMPOs).

Gene McDermott practices in the area of corporate and securities law, with emphasis on capital markets, corporate governance, issuer reporting requirements and mergers and acquisitions. He advises clients involved in public and private offerings of equity and debt, both in the United States and internationally. His work regularly includes general securities advice, tender offers, public and private merger and acquisition transactions and "alternative" public offerings, such as registered directs, PIPEs, at-the-market offering programs and confidentially marketed public offerings (CMPOs).

Gene’s experience includes the representation of:

  • A number of publicly traded companies in their ongoing reporting obligations, corporate governance and compliance matters, financings and strategic transactions
  • Juvenescence Limited, a BVI drug development company focused on the development of therapies to increase human longevity, in its purchase of 14.4 million shares of AgeX Therapeutics, Inc., for $43.2 million, from its affiliate BioTime, Inc. (NYSE American: BTX)
  • NewStar Financial, Inc., a Nasdaq-listed non-bank lender and investment manager specializing in direct lending to middle market companies, in simultaneous transactions through which NewStar was acquired by First Eagle Investment Management by merger, and a $2.4 billion portfolio of loans and other investment assets was sold to an affiliate of GSO Capital Partners in an asset sale
  • Kronos Worldwide, Inc., a NYSE-listed manufacturer of titanium dioxide pigments, in its private offering of €400 million in aggregate principal amount of senior secured notes under Rule 144A and Regulation S
  • ActiveCare Inc., and its wholly-owned subsidiary, 4G Biometrics, LLC, in the sale of substantially all of its assets under Sections 105, 363 and 365 of the United States Bankruptcy Code, to Telcare Medical Supply, LLC, a subsidiary of Biotelemetry, Inc. (NASDAQ: BEAT), a leading developer of mobile and wireless medical monitoring devices, for up to an amount exceeding $10 million of total consideration
  • Heritage Village Water Company in its 2016 merger with Connecticut Water Service Inc. (NASDAQ: CTWS) in a stock-for-stock exchange
  • Textron, Inc., in its acquisition of ATAC Holdings, Inc., a tactical airborne training provider to the U.S. military
  • Firestone Financial Corp. in its stock-for-stock acquisition by Berkshire Hills Bancorp (NYSE: BHLB)
  • Viatel Holding (Bermuda) Limited, a European telecommunications company, in its acquisition by Digiweb, including the equity rollover and additional investment by institutional shareholders
  • Allied Healthcare International Inc. (NYSE: AHCI), a publicly traded homecare provider of health and social care in the United Kingdom and Ireland, in its $175 million acquisition by Saga Group Limited
  • A private equity fund in its senior secured convertible note PIPE investment in a Texas-based, publicly traded health care company as well as in several follow-on investments in the same company
  • A publicly traded Massachusetts-based clean technology company in a series of CMPOs and registered direct offerings as well as other alternative financing arrangements
  • ABRY Partners, a private equity firm, in its $1.3 billion acquisition of RCN Corporation (NASDAQ: RCNI)
  • Takeda Pharmaceutical Company Limited (TSE: 4502) in its $8.8 billion tender offer for Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) in 2008, at the time one of the largest foreign acquisitions by a Japanese company and the largest by a Japanese company in the pharmaceutical industry
  • QBE Insurance Group Limited (AUS: QBE) in its acquisition of North Pointe Holdings Corporation (NASDAQ: NPTE), a specialty commercial and personal lines insurer
  • An NYSE-listed telecommunications company in an issuer tender offer for certain of its employee stock options to address adverse tax consequences to optionholders arising out of an options backdating inquiry
  • GTECH Holdings Corporation in several transactions, including:
    • $175 million offering of guaranteed convertible debentures to qualified institutional investors under Rule 144A, and the resale registration of the same debentures with the SEC
    • $250 million offering of senior notes
    • Acquisition of Interlott Technologies, Inc.
    • Acquisition by Lottomatica S.p.A.
  • Kingsway Financial Services, Inc., a specialty provider of personal and commercial lines of property and casualty insurance in the United States and Canada, in its unsolicited tender offer for all outstanding securities of American Country Holdings Inc.
RELATED EXPERIENCE
RELATED EXPERIENCE
RELATED NEWS & EVENTS
CREDENTIALS
Education
  • J.D., magna cum laude, Georgetown University Law Center, 1995
  • A.B., Stanford University, 1991
Bar Admissions
  • New York
  • Rhode Island
Professional Affiliations
    • Member, Rhode Island Bar Association
Professional History
    • Partner, Locke Lord LLP
    • Associate, Cleary Gottlieb Steen & Hamilton LLP (New York and London)
    • Clerk,Justice Warren Matthews, Alaska Supreme Court (Anchorage)